Clinical Trial Update: Effectiveness of a Biosimilar Epoetin Alfa in Stable 'End Stage Renal Failure'

View source ↗

Summary

A clinical trial evaluates the effectiveness of a biosimilar epoetin alfa in stable patients with end-stage renal disease–related anemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• End-stage Renal Disease

Drugs mentioned

• Epoetin alfa biosimilar (epoetin alfa)

Snippet

Sponsor: Penang Hospital, Malaysia | Conditions: End Stage Renal Failure, Anaemia | Status: UNKNOWN